key: cord-0739582-p2k92nel authors: Bendayan, Marion; Robin, Geoffroy; Hamdi, Safouane; Mieusset, Roger; Boitrelle, Florence title: COVID‐19 in men: With or without virus in semen, spermatogenesis may be impaired date: 2020-10-30 journal: Andrologia DOI: 10.1111/and.13878 sha: ca81794562af23f6d556c414c1aa1f7f4dea1429 doc_id: 739582 cord_uid: p2k92nel nan The SARS-CoV-2 virus uses angiotensin-converting enzyme 2 (ACE2) receptors to enter human cells, and the spike protein (protein S) is primed by transmembrane serine protease (TMPRSS2). The male reproductive system is believed to express both the ACE2 and TMPRSS2 receptor in the testes (spermatogonia, Sertoli and Leydig cells) and in prostate epithelial cells (for a review, see Hamdi et al., 2020; Vishvkarma R, & Rajender S, 2020) . If receptors for the virus are present at different stages of the male reproductive system, it is not unreasonable to think that the virus could be found in semen either by alteration of the blood-testis barrier but also by excretion into prostatic fluid. To date, fives studies have identified no virus in the semen of 91 patients total infected with COVID-19 Holtmann et al., 2020; Pan et al., 2020; Paoli et al., 2020; Song et al., 2020) . While these data were reassuring, a manuscript mentions the presence of virus in the semen of six patients infected with COVID-19 (4 in the acute phase of the disease and 2 cured) . Some authors have questioned the conditions of sperm collection or the detection limits of the quantitative reverse transcription-polymerase chain reaction (qRT-PCR) tests used. It should be noted that the diagnostic accuracy of many commercial quantitative reverse transcription-polymerase chain reaction (qRT-PCR) kits available for the detection of SARS-CoV-2 has a sensitivity and/or specificity <100%. PCR inhibitors are also present in semen (Schrader et al., 2012) . Therefore, both false positive and false negative results could be obtained. Although it is not expected that SARS-CoV-2 clings to sperm, this has not yet been evaluated. For infertile men utilizing assisted reproductive technologies (ARTs), is there not a risk of inoculating the oocyte with the virus during intracytoplasmic sperm injection (ICSI) or the woman's uterus during intrauterine insemination (IUI)? If these questions remain unanswered, ART activities in infertile men must take these factors into account. Beyond the presence or absence of a virus in semen, it is clear that COVID-19 can be accompanied by the deregulation of spermatogenesis. As Sertoli's cells have receptors for SARS-CoV-2, it is not unreasonable to think that they could be infected by the virus and thus see their functions altered (Shen et al., 2020; Verma et al., 2020) . Sertoli's cells play a key role in spermatogenesis and altering them could alter spermatogenesis. Future research would be interesting. It would be possible to study the in vitro impact of SARS-CoV-2 on Sertolian cell lines or more simply to explore in vivo Sertolian hormonal secretions (Anti-Müllerian hormone, inhibin B) in COVID-19 positive patients. This research would allow to assess, if they exist, the potential impacts of the virus on the functions of Sertoli cells. Fever is a symptom observed in over 80% of patients infected with COVID-19. This fever alone can have a negative impact on the physiological mechanisms of scrotal heat regulation, which are overwhelmed when body temperature rises by even one degree Celsius. Therefore, even a fever of limited duration can decrease sperm count and/or motility and may alter sperm DNA integrity. The return to the basal state of the sperm parameters can take a long time, sometimes nearly three months (Sergerie, Mieusset, Croute, Daudin, & Bujan, 2007; Carlsen et al., 2003; Lazarus & Zorgniotti, 1975) . Fever induced by COVID-19 can therefore alter sperm parameters even in the absence of virus in the semen. In infertile men with altered sperm parameters in the basal state, this fever could have a more deleterious impact. For this reason, it has recently been recommended to monitor sperm parameters and to delay ART management for three months in men who have been diagnosed with COVID-19 and developed a fever (Hamdi et al., 2020) . The links between androgens and COVID-19 are complex. Some authors have described a promoting effect of testosterone on the risk of COVID-19 infection (Pozzilli & Lenzi, 2020) . Conversely, one study de- Covid-19, fever, SARS-CoV-2, semen, spermatogenesis All authors help to write this manuscript. Not applicable. Not applicable. Absence of SARS-CoV-2 in Semen of a COVID-19 Patient Cohort COVID-19 and andrology: Recommendations of the French-speaking society of andrology (Société d'Andrologie de langue Française SALF). Basic and Clinical Andrology Assessment of SARS-CoV-2 in human semen-a cohort study Thermoregulation of the human testis Clinical characteristics and results of semen tests among men with coronavirus disease 2019 No evidence of severe acute respiratory syndrome-coronavirus 2 in semen of males recovering from coronavirus disease 2019 Study of SARS-CoV-2 in semen and urine samples of a volunteer with positive naso-pharyngeal swab Commentary: Testosterone, a key hormone in the context of COVID-19 pandemic Low testosterone levels predict clinical adverse outcomes in SARS-CoV-2 pneumonia patients PCR inhibitors -occurrence, properties and removal High risk of temporary alteration of semen parameters after recent acute febrile illness The ACE2 expression in Sertoli cells and germ cells may cause male reproductive disorder after SARS-CoV-2 infection Absence of 2019 novel coronavirus in semen and testes of COVID-19 patients † ACE2 receptor expression in testes: Implications in COVID-19 pathogenesis Could SARS-CoV-2 affect male fertility?